T B Wang1, W S Qiu, B Wei, M H Deng, H B Wei, W G Dong. 1. Department of Gastrointestinal Surgery, The First Affiliated Hospital, SUN Yat-Sen University, 510080 Guangzhou, Guangdong, China. tbw0531@yahoo.com.cn
Abstract
AIM: To investigate if serum vascular endothelial growth factor (SVEGF), tissue VEGF and microvessel density (MVD) have any relation to progress and prognosis in gastrointestinal stromal tumors (GIST). METHODS: SVEGF was examined using ELISA. VEGF and MVD were examined using immunohistochemical staining. RESULTS: The median level of SVEGF was higher in GIST than in controls. A higher level of SVEGF and a positive expression rate of VEGF were obtained in diameter >or=5 cm, mitotic count >or=2/10 high power fields (HPF), recurrence and high risk groups. The MVD of experimental was higher than that of controls. A higher MVD was observed in mitotic count >or=2/10HPF and recurrence groups. The median level of SVEGF was higher in the VEGF positive group than in the controls. The SVEGF presented a relationship with MVD. Factors predicating poor prognosis were SVEGF and VEGF. CONCLUSIONS: SVEGF and VEGF show a correlation with poor prognosis of GIST.
AIM: To investigate if serum vascular endothelial growth factor (SVEGF), tissue VEGF and microvessel density (MVD) have any relation to progress and prognosis in gastrointestinal stromal tumors (GIST). METHODS: SVEGF was examined using ELISA. VEGF and MVD were examined using immunohistochemical staining. RESULTS: The median level of SVEGF was higher in GIST than in controls. A higher level of SVEGF and a positive expression rate of VEGF were obtained in diameter >or=5 cm, mitotic count >or=2/10 high power fields (HPF), recurrence and high risk groups. The MVD of experimental was higher than that of controls. A higher MVD was observed in mitotic count >or=2/10HPF and recurrence groups. The median level of SVEGF was higher in the VEGF positive group than in the controls. The SVEGF presented a relationship with MVD. Factors predicating poor prognosis were SVEGF and VEGF. CONCLUSIONS: SVEGF and VEGF show a correlation with poor prognosis of GIST.
Authors: W Famulski; M Sulkowska; A Wincewicz; B Kedra; K Pawlak; B Zalewski; S Sulkowski; M Koda; M Baltaziak Journal: Neoplasma Date: 2006 Impact factor: 2.575
Authors: S Arita; F Kikkawa; H Kajiyama; K Shibata; M Kawai; K Mizuno; T Nagasaka; K Ino; S Nomura Journal: Int J Gynecol Cancer Date: 2005 Mar-Apr Impact factor: 3.437
Authors: George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu Journal: N Engl J Med Date: 2002-08-15 Impact factor: 91.245
Authors: K N Ganjoo; V M Villalobos; A Kamaya; G A Fisher; J E Butrynski; J A Morgan; A J Wagner; D D'Adamo; A McMillan; G D Demetri; S George Journal: Ann Oncol Date: 2014-01 Impact factor: 32.976
Authors: Stavros P Papadakos; Christos Tsagkaris; Marios Papadakis; Andreas S Papazoglou; Dimitrios V Moysidis; Constantinos G Zografos; Stamatios Theocharis Journal: World J Gastrointest Oncol Date: 2022-08-15